CARD15/NOD2 in a Tunisian population with Crohn's disease

Digestive Diseases and Sciences

Volumn 50, Issue 1, 2005, Pages 130-135

  Zouiten Mekki, Lilia ^a   Zaouali, Habib ^b   Boubaker, Jalel ^a   Karoui, Sami ^a   Fekih, Monia ^a   Matri, Samira ^a   Hamzaoui, Sami ^a   Filali, Azza ^a   Chaabouni, Habiba ^c   Hugot, Jean Pierre ^b  

^a LA RABTA HOSPITAL   (Tunisia)

^b FONDATION JEAN DAUSSET CEPH   (France)

^c CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Crohn's disease; Human; NOD2 CARD15 gene; Tunisia

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; ARGININE; CARD15 PROTEIN, HUMAN; GLYCINE; SIGNAL PEPTIDE; TRYPTOPHAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ETHNIC DIFFERENCE; EUROPE; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; TUNISIA; WESTERN HEMISPHERE; CASE CONTROL STUDY; GENETICS; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARGININE; CASE-CONTROL STUDIES; CROHN DISEASE; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; GLYCINE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; TRYPTOPHAN; TUNISIA; VARIATION (GENETICS);

EID: 20044377215     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-1290-0     Document Type: Article

References (35)

1. Ogura Y, Bonen DK, Inohra N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirshner BS, Hanauer SB, Nunez G, Cho JH: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606, 2001
2. Elson CO: Genes, microbes and T cells: new therapeutic targets in Crohn's disease. N Engl J Med 346:614-616, 2002
3. Ahmad T, Satsangi D, MCGovern M, Bunce M, Jewell DP: The genetics of inflammatory bowel disease. Aliment Pharmacol Ther 15:731-748, 2001
4. Cho JH, Nicolae DL, Gold LH, Fields CT, Labuda MC, Rohal PM, Pickels MR, Qin L, Fu Y, Mann JS, Kirschner BS, Jabs EW, Weber J, Hanauer SB, Bayless TM, Brant SR: Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA 95:7502-7507, 1998
5. Duerr RH, Barmada MM, Zhang L, Pfutzer R, Weeks DE: High density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet 66:1857-1862, 2001
6. Satsangi J, Parkes M, Louis E: Two stage genome wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 14:199-202, 1996
7. Satsangi J, Welsh KI, Bunce M: Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347:1212-1217, 1996
8. Hugot JP, Laurent Puig P, Gower Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti Pellie C, Weissenbach J, Matew CG, Lennard Jones JE, Cortot A, Colombel JF, Thomas G: Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379:821-822, 1996
9. International IBD Genetics Consortium: International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn's disease and chromosome 16. Am J Hum Genet 68:1165-1171, 2001
10. Ohmen JD, Yang H, Yamomoto KK: Susceptibility locus for IBD on chromosome 16 has a role in Crohn's disease but not in ulcerative colitis. Hum Mol Genet 5:1679-1683, 1996
11. Hugot JP, Chamaillard M, Wouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassul M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent Puig P, Gower Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G: Association of NOD 2 leucine repeat variants with susceptibility to Crohn's disease. Nature 411:599-603, 2001
12. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, Van Deventer S, Forbes A, Nikolaus S, Lennard Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357:1925-1928, 2001
13. Ogura Y, Inohra N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod 2, a Nod 1/Apaf 1 family member that is restricted to monocytes and activates NFκB. J Biol Chem 276:4812-4818, 2001
14. Inohara N, Ogura Y, Chen FF: Human Nodi confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 276:2551-2554, 2003
15. Hisamatsu T, Suwuki M, Reinecker HC, Nadeau WJ, Mccormick BA, Podolosky DK: CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124:993-1000, 2003
16. Bonen DK, Ogura Y, Nicolae DL, et al.: Crohn's disease associated NOD2 variants share a signaling defect in response to lipopolysaccharides and peptidoglycan. Gastroenterology 124:140-146, 2003
17. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M: Host recognition of bacterial muramyl dipeptide medited through NOD2. Implication for Crohn's disease. J Biol Chem 278:5509-5512, 2003
18. Rosenstiel P, Fantini M, Brautigam K, Kuhbacher T, Waetzig GH, Seegert D, Schreiber S: TNFα and INFγ regulate the expression of the NOD2/CARD15 gene in human intestinal epithelial cells. Gastroenterology 124:1001-1009, 2003
19. Cho JH: Significant role of genetics in IBD: the NOD2 gene. Rev Gastroenterol Disord 3 (Suppl 1):S18-S22, 2003
20. Mehdi A, Baccouche A: Epidemiologie des maladies inflammatoires cryptogenetiques de l'intestin dans le centre est de la Tunisie. Maghreb Med 314:47-52, 1997
21. Lennard-Jones JE: Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2-6, 1989
22. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
23. Lesage S, Zouali H, Cezard JP, et al.: CARD 15NOD2 mutational analysis and genotype phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70:845-857, 2002
24. Barmada MM, Brant SR, Nicolae DL, Achkar JP, Panhuysen CI, Bayless TM, Cho JH, Duerr RH: A genome scan in 260 inflammatory bowel disease affected relative pairs Inflamm Bowel Dis 10:15-22, 2004
25. Vermeire S, Wild G, Kocher K, Cousineau J, Dufresne L, Bitton A, Langlier D, Pare P, Lapointe G, Cohen A, Daly MJ, Rioux JD: CARD15 genetic variation in a Quebec population: prevalence, genotypephenotype relationschip and haplotype structure. Am J Hum Genet 71:74-83, 2002
26. Cavanaugh JA, Adams KE, Quak EJ, Bryce ME, O'Callaghan NJ, Rodgers HJ, Magarry GR, Butler WJ, Baden JA, Roberts-Thomson IC, Pavli P, Wilson SR, Callen DF: CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian population. Ann Hum Genet 67:35-41, 2003
27. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, Inohara N, Nunez G, Kishi Y, Koike Y, Shimosegawa T, Shimoyama T, Hibi T: Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 123:86-91, 2002
28. Leong RW, Armuzzi A, Ahmad T, Wong ML, Tse P, Jewell DP, Sung JJ: NOD2/CARD15 gene polymorphisms ans Crohn's disease in the Chinese population. Aliment Pharmacol Ther 17:1465-1470, 2003
29. Arnott ID, Nimmo ER, Drammond HE, Fennell J, Smith BR, MacKinlay E, Morecroft J, Anderson N, Kelleher D, O'Sullivan M, McManus R, Satsangi J: NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe. Genes Immun Jun 10, 2004
30. Sugimura K, Taylor KD, Lin Y, Hang T, Wang D, Tang YM, Fishel-Ghodsian N, Targan SR, Rotter JI, Yang H: A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet 72:509-518, 2003
31. Vavassori P, Borgiani P, Biancone L, D'apice MR, Blancogdel V, Vallo L, De nigris F, Monteleone I, Monteleone G, Pallone I, Novelli G: CARD15 mutations analysis in Italian population. Inflamm Bowel Dis 10:116-121, 2004
32. Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH: MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 73(6):1282-1292, 2003
33. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Deviere J, Rutgeerts P: Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53:987-992, 2004
34. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, Newman B, Van Oene M, Cescon D, Greenberg G, Griffiths AM, St George-Hyslop PH, Siminovitch KA: Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36(5):471-475, 2004
35. Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, Koch WA, Rosenstiel P, Albrecht M, Croucher PJ, Seegert D, Nikolaus S, Hampe J, Lengauer T, Pierrou S, Foelsch UR, Mathew CG, Lagerstrom-Fermer M, Schreiber S: Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36(5):476-480, 2004